Grace Therapeutics, Inc. Derivative Liability, Noncurrent
Grace Therapeutics, Inc. (GRCE) had Derivative Liability, Noncurrent of $201.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2025-11-13
- 2025-09-30: Derivative Liability, Noncurrent $201.00K.
- 2025-06-30: Derivative Liability, Noncurrent $1.63M.
- 2025-03-31: Derivative Liability, Noncurrent $1.14M.
- 2024-12-31: Derivative Liability, Noncurrent $3.78M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.63M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.14M 10-Q · filed 2025-11-13 |
| 2024-12-31 | $3.78M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $2.60M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.96M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $4.36M 10-K · filed 2025-06-23 |
| 2023-12-31 | $3.33M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $3.46M 10-Q · filed 2023-11-13 |
| 2023-03-31 | $0.00 10-K · filed 2024-06-21 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-14 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-03-31 | $10.00K 10-K · filed 2023-06-23 |
| 2021-12-31 | $268.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $1.12M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $4.65M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.22M 10-K · filed 2022-06-21 |
| 2020-12-31 | $2.34M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $1.17M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $3.07M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.39M 10-K · filed 2021-06-22 |
| 2019-03-31 | $12.18M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |